Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001450107 | SCV001653704 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000863372 | SCV001747122 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003528239 | SCV004357412 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-08-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004002929 | SCV004814819 | likely benign | Marfan syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003528239 | SCV005032583 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |